Cardiovascular
-
Cost-effectiveness of clopidogrel in STEMI patients in the Netherlands: a model based on the CLARITY trial.
Thurston SJ, Heeg B, de Charro F, van Hout B. Current Medical Research and Opinion. 2010;26(3):641-51.
-
Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer's perspective.
Heeg B, Damen J, Van Hout B. Pharmacoeconomics. 2007;25(12):1063-82. Review.
-
Long-term clopidogrel therapy in patients receiving percutaneous coronary intervention.
Heeg BM, Peters RJ, Botteman M, van Hout BA. Pharmacoeconomics. 2007;25(9):769-82.
-
Economic impacts attributable to the early clinical benefit of atorvastatin therapy--a US managed care perspective.
Straka RJ, Mamdani M, Damen J, Kuntze CE, Liu LZ, Botteman MF, Koren MJ. Curr Med Res Opin. 2007;23(7):1517-29.
-
Effect of treating erectile dysfunction on management of systolic hypertension.
Scranton RE, Lawler E, Botteman M, Chittamooru S, Gagnon D, Lew R, Harnett J, Gaziano JM. Am J Cardiol. 2007;100(3):459-63.
-
Determinants and prognostic significance of collaterals in patients undergoing coronary revascularization.
Nathoe HM, Koerselman J, Buskens E, van Dijk D, Stella PR, Plokker TH, Doevendans PA, Grobbee DE, de Jaegere PP; Octopus Study Group. Am J Cardiol. 2006;98(1):31-5.
-
Endograft treatment of ruptured abdominal aortic aneurysms using the Talent aortouniiliac system: an international multicenter study.
Peppelenbosch N, Geelkerken RH, Soong C, Cao P, Steinmetz OK, Teijink JA, Lepantalo M, De Letter J, Vermassen FE, DeRose G, Buskens E, Buth J. J Vasc Surg. 2006;43(6):1111-1123; discussion 1123.
-
The use of a surgical sealant (CoSeal(R)) in cardiac and vascular reconstructive surgery: an economic analysis.
Buskens E, Meijboom MJ, Kooijman H, Van Hout BA. J Cardiovasc Surg (Torino). 2006;47(2):161-70.
-
Direct Costs of Surgical Clipping and Endovascular Coiling of Unruptured Intracranial Aneurysms.
Halkes PH, Wermer MJ, Rinkel GJ, Buskens E. Cerebrovasc Dis. 2006;22(1):40-5.
-
Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
van Stel HF, Buskens E.Health Qual Life Outcomes. 2006;4(1):20.
-
No nonagenarians please!
Buskens E. Arch Surg. 2006;141(1):104.
-
Dutch iliac stent trial: long-term results in patients randomized for primary or selective stent placement.
Klein WM, van der Graaf Y, Seegers J, Spithoven JH, Buskens E, van Baal JG, Buth J, Moll FL, Overtoom TT, van Sambeek MR, Mali WP. Radiology. 2006;238(2):734-44.
-
Optimal peak systolic velocity threshold at duplex us for determining the need for carotid endarterectomy: a decision analytic approach.
Heijenbrok-Kal MH, Buskens E, Nederkoorn PJ, van der Graaf Y, Hunink MG. Radiology. 2006 Feb;238(2):480-8.
-
Perioperative myocardial ischemic injury in high risk vascular surgery patients: Incidence and clinical significance in a prospective clinical trial.
Mackey WC, Fleisher LA, Haider S, Sheikh S, Cappelleri JC, Lee WC, Wang Q, Stephens JM. J Vasc Surg 2006;43; 533-8.
-
Cost-effectiveness of clopidogrel vs. aspirin treatment in high-risk acute coronary syndrome patients in Denmark
Heeg B, van Gestel A, Hout B, Olsen J, Haghfelt TH. Ugeskr Laeger. 2006;168(35):2911-5. In Danish.
|
,
View by subject
|